Phase
Condition
Osteoarthritis
Treatment
Synovectomy
Partial synovectomy
Clinical Study ID
Ages 41-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Males or females over the age of 40 diagnosed with knee osteoarthritis
Scheduled for first unilateral total knee arthroplasty
Moderate to severe (at least grade two) synovitis and synovial hyperplasia, asdetermined by ultrasound assessment
Referred to the Pre-Admission Clinic at University Hospital
Exclusion
Exclusion Criteria:
Bilateral, uni-compartmental, or revision total knee arthroplasty
Osteoarthritis due to genetic syndromes (e.g., Ehlers-Danlos Syndrome, etc.)
Known inflammatory arthropathy, another rheumatic disease, or disease-modifyinganti-rheumatic drug (DMARD) use (e.g. methotrexate, hydroxychloroquine,sulfasalazine, leflunomide, TNF inhibitors, etc.) - note: Gout is NOT an exclusion
Joint injection (steroid or viscosupplement) within 12 weeks of Pre-Admission Clinicappointment date
Cannot read, write, or understand English (printed instructions are provided inEnglish only)
Any factors precluding patients from attending follow-up appointments (e.g.,socio-economic limitations, distance from clinic, no access to home/cell phone,etc.).
Cognitive impairment or psychological problems that preclude the ability tounderstand instructions
Not able to follow up at routine standard of care post-operative visits
Study Design
Connect with a study center
London Health Sciences Centre - University Hospital
London, Ontario N6A 5W9
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.